Package 60219-1416-3

{"route": ["ORAL"], "spl_id": "992e50d5-b6c2-4213-9c7c-ef25c84d0708", "openfda": {"upc": ["0360219141735"], "unii": ["4U07F515LG"], "rxcui": ["825421", "825427", "884617", "1245001"], "spl_set_id": ["05acf38e-7870-4809-a045-fc38e66b1110"], "manufacturer_name": ["Amneal Pharmaceuticals NY LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60219-1416-3)", "package_ndc": "60219-1416-3", "marketing_start_date": "20260115"}], "brand_name": "Eltrombopag Olamine", "product_id": "60219-1416_992e50d5-b6c2-4213-9c7c-ef25c84d0708", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Breast Cancer Resistance Protein Inhibitors [MoA]", "Increased Megakaryocyte Maturation [PE]", "Increased Platelet Production [PE]", "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]", "Thrombopoietin Receptor Agonist [EPC]", "Thrombopoietin Receptor Agonists [MoA]", "UGT1A1 Inhibitors [MoA]", "UGT1A3 Inhibitors [MoA]", "UGT1A4 Inhibitors [MoA]", "UGT1A6 Inhibitors [MoA]", "UGT1A9 Inhibitors [MoA]", "UGT2B15 Inhibitors [MoA]", "UGT2B7 Inhibitors [MoA]"], "product_ndc": "60219-1416", "generic_name": "Eltrombopag", "labeler_name": "Amneal Pharmaceuticals NY LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Eltrombopag Olamine", "active_ingredients": [{"name": "ELTROMBOPAG OLAMINE", "strength": "25 mg/1"}], "application_number": "ANDA212884", "marketing_category": "ANDA", "marketing_start_date": "20260115", "listing_expiration_date": "20271231"}